BRD4: Products

"BRD4" has 21 results in Products.
Sort by:

(+)-JQ1 

Potent and selective BET bromodomain inhibitor; cell permeable

MZ 1 

(+)-JQ1 based Degrader (PROTAC®) that preferentially degrades BRD4

I-BET 151 dihydrochloride 

BET bromodomain inhibitor; also promotes differentiation of hiPSCs into megakaryocytes

XMD 8-92 

ERK5/BMK1 inhibitor; also BRD4 inhibitor

cis MZ 1 

Negative Control for MZ 1 (Cat. No. 6154)

dBET1 

(+)-JQ1 based Degrader (PROTAC®) targeting BET bromodomains, active in vivo

dBET6 

Potent and selective (+)-JQ1 based Degrader (PROTAC®) targeting BET bromodomains, active in vivo

PFI 1 

BET bromodomain inhibitor

Bromosporine 

Broad spectrum bromodomain inhibitor

CPI 203 

BET bromodomain inhibitor; arrests cell cycle at G1 phase

OTX 015 

BET bromodomain inhibitor; orally bioavailable

AT 1 

(+)-JQ1 based PROTAC® with selectivity for BRD4

I-BET 762 

Potent and high affinity BET bromodomain inhibitor; anti-inflammatory; orally bioavailable.

ARV 771 

Potent BET bromodomain PROTAC®; also degrades BRD-tagged chimeric antigen receptors (CAR) in T cells

BRD PHOTAC-I-3 

Photoswitchable BET bromodomain Degrader (PHOTAC)

iBET-BD2 

Potent and selective pan-BD2 inhibitor; orally bioavailable

SGC SMARCA-BRDVIII 

Potent and selective SMARCA2/4 and PB1(bromo 5)-selective SWI/SNF bromodomain inhibitor

(+)-JQ1 bump, acid functionalized 

Functionalized BET bromodomain ligand; precursor for Tag Degraders

(+)-JQ1 maleimide 

JQ1-maleimide functionalized probe; induces proteasomal degradation of BRD4

JQ1-FITC 

Fluorescent BET bromodomain probe; suitable for use in TR-FRET
page of 1